The activity of enviroxime against rhinovirus infection in man.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D002559:Cerebrospinal Fluid Rhinorrhea / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010091:Oximes; D012229:Rhinovirus / Q000302:isolation & purification; D013449:Sulfonamides
D000998:Antiviral Agents; D001562:Benzimidazoles; D010091:Oximes; D013449:Sulfonamides; C021595:viroxime